LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 388 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $204,000 | -50.5% | 1,500 | 0.0% | 0.08% | -38.3% |
| Q3 2018 | $412,000 | +32.5% | 1,500 | 0.0% | 0.13% | +28.0% |
| Q2 2018 | $311,000 | -35.1% | 1,500 | -48.3% | 0.10% | -37.9% |
| Q1 2018 | $479,000 | +20.7% | 2,900 | 0.0% | 0.16% | +19.3% |
| Q4 2017 | $397,000 | +94.6% | 2,900 | +93.3% | 0.14% | +80.0% |
| Q3 2017 | $204,000 | – | 1,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |